-
Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout
cphi-online
May 24, 2021
CPhI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges
-
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
prnasia
May 24, 2021
Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273, Moderna's COVID-19 vaccine.
-
EC to procure 1.8 billion doses of Pfizer-BioNTech’s Covid-19 vaccine
pharmaceutical-technology
May 24, 2021
The European Commission (EC) has signed a new contract with BioNTech and Pfizer to procure additional 1.8 billion doses of their Covid-19 vaccine, Comirnaty, between this year end to 2023.
-
Two AstraZeneca COVID shots 85-90 per cent effective, says UK real-world analysis
expresspharma
May 24, 2021
Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine rollouts, generating a lot of data about the use of the shots in real-world settings.
-
BioNTech says vaccine likely to be effective against Indian variant
expresspharma
May 24, 2021
BioNTech SE said yesterday that the COVID-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.
-
S Korea approves Moderna’s COVID-19 vaccine
expresspharma
May 24, 2021
The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States.
-
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report
expresspharma
May 24, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries.
-
Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine
expresspharma
May 24, 2021
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service.
-
Pharm-Olam is now enrolling UK volunteers into a pivotal Phase III COVID-19 vaccine study
prnewswire
May 21, 2021
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases, vaccines, rare diseases, and oncology, is now enrolling UK volunteers into a pivotal Phase III COVID-19 vaccine study.
-
Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey
contractpharma
May 21, 2021
Pfizer and BioNTech Europe GmbH have entered an agreement with Turkey’s Ministry of Health to supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses.